Durable and reversible epigenetic programming of human hematopoietic stem cells as a platform for modulation of platelet function
Cell Stem Cell · 2026-11
DOI: 10.1016/j.stem.2026.10.009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Stem Cell, 2026-11. Verfasst von Tianyi Ye und 21 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA; Department of Pediatric Oncology, Dana-Fa…. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIDDK NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA;…
- Vascular Biology Program, Boston Children's Hospital, Boston, MA 02115, USA; Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
- Cardiovascular Research Center, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA; Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA.
- Cardiovascular Research Center, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA; Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA; Division of Hemostasis and T…
- Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA; Department of Biology and Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, MA 02142, USA; David H. Koch Institute…
Förderung
- NCI NIH HHS
- NIDDK NIH HHS
- NHLBI NIH HHS
- National Institutes of Health
- Howard Hughes Medical Institute
Zitieren
APA
Ye, T., Xu, W., Barrachina, M. N., Lyu, P., Antoszewski, M., Della Volpe, L., Guo, C. J., Lee, A. J., Villalpando, E., Johnson, I. A., Theardy, M. S., Shelton, S. D., Wahlster, L., Caulier, A., Messa, L., Poeschla, M., Agarwal, G., Mitra, R., Schmaier, A. A., …, & Sankaran, V. G. (2026). Durable and reversible epigenetic programming of human hematopoietic stem cells as a platform for modulation of platelet function. Cell Stem Cell. https://doi.org/10.1016/j.stem.2026.10.009
Vancouver
Ye T, Xu W, Barrachina MN, Lyu P, Antoszewski M, Della Volpe L, et al. Durable and reversible epigenetic programming of human hematopoietic stem cells as a platform for modulation of platelet function. Cell Stem Cell. 2026. doi:10.1016/j.stem.2026.10.009
BibTeX
@article{Ye2026,
author = {Ye, Tianyi and Xu, Wanying and Barrachina, Maria N and Lyu, Peng and Antoszewski, Mateusz and Della Volpe, Lucrezia and Guo, Chun-Jie and Lee, Andrew J and Villalpando, Emily and Johnson, Isaac A and Theardy, Madelaine S and Shelton, Spencer D and Wahlster, Lara and Caulier, Alexis and Messa, Luana and Poeschla, Michael and Agarwal, Gaurav and Mitra, Ronodeep and Schmaier, Alec A and Weissman, Jonathan S and Machlus, Kellie R and Sankaran, Vijay G},
title = {Durable and reversible epigenetic programming of human hematopoietic stem cells as a platform for modulation of platelet function},
journal = {Cell Stem Cell},
year = {2026},
doi = {10.1016/j.stem.2026.10.009}
}
EUVIMED